ArriVent BioPharma, Inc. (AVBP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 773.87M |
| Enterprise Value | 728.34M |
| P/E Ratio | -8.99 |
| PEG Ratio | -8.77 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.41 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -9.75 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.42 |
| Return On Equity | -0.49 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -166.31M |
| Net Income | -166.31M |
| Diluted EPS | -4.32 |
Balance Sheet
| Total Cash | 326.38M |
| Total Cash/Share | 7.24 |
| Total Debt | 419,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 13.95 |
| Book Value Per Share | 7.19 |
Price History
| 52-Week Change | 51.6 |
| 52-Week High | 35.83 |
| 52-Week Low | 16.1 |
| Moving Average 50 Days | 31.02 |
| Moving Average 200 Days | 25.08 |
Statistics
| Average Volume | 552,937 |
| Shares Outstanding | 46.57M |
| % Held by Institutions | 109.72 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
